Loading…

Efficacy and Safety of Glecaprevir/pibrentasvir in a Patient With HCV-Induced Porphyria Cutanea Tarda Receiving Vedolizumab for Crohn´s Disease

Saved in:

Bibliographic Details
Published in:	Journal of Crohn's and colitis 2020-05, Vol.14 (4), p.567-568
Main Authors:	Rojo, E, Chaparro, M, García-Buey, L
Format:	Article
Language:	English
Subjects:	Aminoisobutyric Acids - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Benzimidazoles - therapeutic use Crohn Disease - complications Crohn Disease - drug therapy Cyclopropanes - therapeutic use Gastrointestinal Agents - therapeutic use Hepatitis C - complications Hepatitis C - drug therapy Humans Lactams, Macrocyclic - therapeutic use Leucine - analogs & derivatives Leucine - therapeutic use Male Middle Aged Porphyria Cutanea Tarda - drug therapy Porphyria Cutanea Tarda - virology Proline - analogs & derivatives Proline - therapeutic use Quinoxalines - therapeutic use Sulfonamides - therapeutic use
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!